Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Shahid Rameez, Ph.D. is a Principal Scientist, Process Development at KBI Biopharma Inc. Shahid has experience in CMC activities responsible for design, development, and implementation of efficient and robust cell culture processes for small and large scale manufacturing using various expression systems. His expertise are in scale-up/scale-down, process characterization, high-throughput cell culture development, cell culture clarification and technology transfer for phase I through phase III process development. He has led in formulating the development strategy and pathway (FIH and Phase III processes) needs of over 12 biologic programs, which include monoclonal and bispecific antibodies, fusion proteins and biosimilars targeted for various clinical indications. Prior to joining KBI in 2012, Shahid did his doctoral and post-doctoral studies at The Ohio State University on designing cellular protein therapeutics. He has over 10 publications in the area of process development and protein therapeutics.